
Opinion|Videos|August 21, 2024
Navigating the Clinical and Economic Landscape of Hepatic Encephalopathy (HE)
HE poses significant clinical and economic burdens, with admissions costing tens of thousands of dollars and frequent readmissions, impacting patients, caregivers, and the healthcare system.
Advertisement
Episodes in this series

This series was supported by Salix Pharmaceuticals.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
ASH 2025 Offers Data That Could Make Novel Therapies More Accessible
2
52-Week VERIFY Data Show Rusfertide Brings Sustained Responses in PV
3
Once-Monthly Maridebart Cafraglutide Shows Up to 16% Weight Loss
4
New TROP2-Targeted ADC Shows Promise in TNBC: Erika Hamilton, MD
5









































